forgemax.FORGED. TESTED. PROVEN.
Primobolan 25mg/tab 100 Tabletten by Rossiaz Lab
GMP Standard

Primobolan 25mg/tab 100 Tabletten by Rossiaz Lab

Rossiaz Lab Primobolan 25mg/tab (100 tablets) supplies Methenolone Acetate at 25 mg per tablet — a unit dose calibrated for multi-compound stacking architectures where Methenolone's non-aromatising, low-androgenic profile reinforces adjacent agents without introducing estrogenic or hepatotoxic variables. Every batch is manufactured under GMP-certified conditions and cleared for distribution only after reversed-phase HPLC potency confirmation and LAL endotoxin screening at the finished-tablet stage.

€95.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Serves as a low-oestrogenic anchor compound in multi-agent cutting stacks
  • 25 mg per tablet allows flexible daily split-dosing to fit partner-compound schedules
  • Preserves nitrogen balance when co-administered alongside caloric-deficit protocols
  • Non-aromatising profile reduces the oestrogen-management burden of the overall stack
  • Compatible with both oral-only and mixed oral/injectable stack architectures
  • Mild androgenic index makes it suitable for extended competition-prep cycles alongside harsher compounds
  • GMP-certified batch release with HPLC potency verification on every lot

Key takeaways

  • Use Primobolan as a synergy base layer alongside Testosterone Propionate or Stanozolol.
  • Stack with Oxandrolone for additive lean-mass gains without aromatisation.
  • Split 25 mg tablets across two to three daily doses in any multi-compound protocol.
  • Monitor HDL cholesterol every four weeks when combining two oral androgens.
  • Begin PCT timing based on the longest-ester compound in your stack, not Methenolone.

Methenolone Acetate as a Synergistic Stack Component

Rossiaz Lab Primobolan 25mg/tab is a 25 mg-per-tablet oral Methenolone Acetate preparation whose primary clinical value lies in its ability to potentiate the effects of co-administered compounds without introducing the confounding variables — aromatisation, significant hepatotoxicity, or progestagenic activity — that complicate interpretation and management of multi-compound protocols. Methenolone Acetate contributes a low aromatisation rate to any stack, meaning that compounds running alongside it are not forced to compete with rising oestrogen load for receptor space or for SHBG binding sites. This makes Rossiaz Lab Primobolan a structurally compatible base layer for a wide range of cutting and lean-mass cycles.

How Stacking Amplifies Results Compared to Solo Use

Stacking Methenolone Acetate with compounds such as Testosterone Propionate, Stanozolol, or Oxandrolone creates complementary receptor and metabolic activity that neither agent achieves alone. Testosterone Propionate supplies androgenic drive and libido support that Methenolone Acetate — used in isolation at conservative doses — does not fully replicate; Methenolone in return preserves nitrogen balance and lean tissue economy during the caloric deficit that a cutting phase demands, protecting the gains driven by the co-administered androgen. Stanozolol stacked with Methenolone Acetate addresses two distinct tissue targets simultaneously: Stanozolol reduces SHBG by an estimated 50 % in published in-vitro assays, measured by competitive binding methodology, increasing the fraction of unbound Testosterone or other androgens available for receptor interaction, while Methenolone sustains anabolic tone throughout. Oxandrolone and Methenolone Acetate are frequently paired because both share a preference for lean-mass maintenance over hypertrophic volume accumulation, making the combination disproportionately effective in athletes whose primary metric is strength-to-bodyweight ratio rather than scale weight.

Which Combinations Make the Best Use of the Synergistic Effect

For a structured lean-mass or competition-prep cycle, three combination archetypes are most consistent with the published pharmacological rationale:

Methenolone Acetate + Testosterone Propionate

Primobolan supplies the low-oestrogenic anabolic base; Testosterone Propionate provides the androgenic stimulus absent when Methenolone is used as the sole androgen. Together they create a hormonal environment where tissue quality is prioritised over fluid retention.

Methenolone Acetate + Stanozolol

Stanozolol's documented SHBG-suppressing action, quantified via competitive protein-binding assays in the endocrinology literature, synergises with Methenolone's nitrogen-retaining properties. The net effect is a higher free-androgen fraction and sustained anabolic support with no aromatisation contribution from either compound.

Methenolone Acetate + Oxandrolone

Both agents share a non-aromatising, hepatically mild profile. Combined, they deliver additive anabolic stimulus while keeping oestrogen-related side-effect management requirements minimal — a meaningful advantage in longer contest-prep phases. Each 25 mg Rossiaz Lab tablet is produced under GMP-certified manufacturing controls; potency is confirmed by reversed-phase HPLC quantification and endotoxin clearance by LAL testing before batch release.

Usage

  1. Define your synergy goal before selecting a partner compound — lean-mass retention, SHBG suppression, or strength-to-bodyweight optimisation each points to a different stacking partner alongside Rossiaz Lab Primobolan 25mg.
  2. Divide the daily Methenolone Acetate dose across two to three administrations to maintain stable plasma levels throughout the day and coordinate peak windows with any co-administered oral compound.
  3. If stacking with Testosterone Propionate, time the Primobolan morning dose 30–60 minutes before the first meal and administer Testosterone Propionate at a separate sub-cutaneous or intramuscular site on the same day.
  4. When combining with Stanozolol, stagger the two orals by at least one hour to reduce peak GI load; both compounds are best absorbed alongside a low-fat, moderate-protein meal.
  5. Monitor serum lipid panels every four weeks during any multi-compound protocol; HDL suppression is additive across stacked oral androgens, so the combination of two oral agents warrants closer lipid surveillance than either compound alone.
  6. Plan PCT timing relative to the shortest half-life compound in your stack — Methenolone Acetate clears rapidly, so if it is the sole oral in the protocol, PCT can begin within three to five days of the final dose; if a long-ester injectable is in the stack, PCT timing is governed by that ester's clearance window.

Warnings

contraindications: Not for use in individuals with prostate or breast carcinoma, hepatic impairment, or active cardiovascular disease. Women of childbearing potential should avoid use due to virilisation risk. Not indicated for persons under 21 years of age.

side_effects: Oral Methenolone Acetate suppresses endogenous testosterone production in a dose- and duration-dependent manner. HDL cholesterol reduction is documented with oral androgens; the reduction is compounded when stacking with a second oral agent such as Stanozolol or Oxandrolone. Androgenic effects including acne and hair-loss acceleration may occur in genetically predisposed individuals. Hepatic stress is lower than with 17-alpha-alkylated compounds but is not absent; ALT/AST monitoring remains advisable.

monitoring: Serum lipid panel (HDL, LDL, triglycerides) every 4 weeks during multi-compound cycles. Liver function tests (ALT, AST, ALP) at baseline and every 4–6 weeks. Haematocrit monitoring if cycle duration exceeds 8 weeks. Blood pressure recording at least weekly throughout the stack.

pct: A structured PCT protocol is required following any cycle in which Methenolone Acetate is used, regardless of whether it constitutes the sole agent. For combined protocols involving a Testosterone ester, begin PCT after the injectable compound has cleared (typically 14–21 days after the final Testosterone Propionate injection). Standard SERM-based PCT (Nolvadex or Clomid) for a minimum of four weeks is recommended to restore endogenous HPG axis function.

Frequently asked questions

Which compounds create the strongest synergy when stacked with oral Primobolan Methenolone Acetate?
Testosterone Propionate, Stanozolol, and Oxandrolone are the three most pharmacologically complementary partners. Testosterone Propionate covers the androgenic drive that Methenolone alone does not fully supply; Stanozolol suppresses SHBG — increasing free-androgen availability — while Methenolone maintains nitrogen balance; Oxandrolone pairs with Methenolone for an additive, non-aromatising lean-mass stimulus in longer contest-prep windows.
How does stacking Primobolan with another compound amplify results beyond what either agent delivers solo?
Stacking works through complementary mechanisms rather than simple dose addition. Methenolone Acetate contributes nitrogen retention and a negligible aromatisation rate, which keeps oestrogen load low so partner androgens can exert their full receptor-level effect without estrogenic interference. The net outcome — maintained lean tissue, higher free-androgen fraction, and controlled side-effect profile — exceeds what either compound achieves when used in isolation at equivalent doses.
What is the best stacking combination for a competition-prep cycle using oral Primobolan 25mg tablets?
For contest prep, Methenolone Acetate 50 mg/day combined with Oxandrolone 20–40 mg/day is a widely documented lean-mass and strength-quality pairing. Both compounds are non-aromatising and relatively hepatically mild, allowing extended cycle lengths of 6–10 weeks. The combination minimises oestrogen-management requirements and keeps water retention negligible, which is directly relevant to stage conditioning.
How does the 25 mg tablet strength of Rossiaz Lab Primobolan give an advantage when fine-tuning a multi-compound stack?
At 25 mg per tablet — the highest per-tablet concentration in this oral Primobolan group — Rossiaz Lab's format allows precise daily adjustments in 25 mg increments without the need to split tablets. This granularity is particularly useful when coordinating Methenolone dosing alongside partner compounds whose schedules change mid-cycle, giving practitioners tighter control over the total daily androgen load at each phase of the protocol.
Are oral Primobolan tablets in a jar or blister format, and does the packaging support discreet daily dosing?
Rossiaz Lab Primobolan 25mg/tab (100tabs) is presented in a sealed 100-tablet container. The format is compact, portable, and does not require refrigeration, making split-daily dosing — necessary in synergistic stacking protocols where Methenolone Acetate is taken two to three times per day — straightforward to manage in any setting. The labelling is production-standard with full lot-traceability data printed on the exterior. (2) angle_used

Manufacturer

Rossiaz Lab's distribution model for its oral androgen line is built around one logistical priority that directly shapes product availability at the regional level: analytical release documentation travels with the product through every tier of the supply chain rather than remaining archived at the manufacturing site. For Primobolan 25mg/tab, this means that a verified reseller receiving stock in the UK, Western Europe, or a North American fulfilment hub receives the same lot-traceable Certificate of Analysis — covering reversed-phase HPLC potency quantification and LAL endotoxin clearance — that was generated at finished-tablet release. The practical consequence is that downstream quality claims are not dependent on the reseller's own testing capacity; the documentation originating from GMP-certified production is already attached to the batch. Rossiaz Lab supports this chain through a batch-specific online verification system that allows end users to cross-reference the printed lot code on their Primobolan 25mg pack against the posted analytical data, confirming both potency conformance and endotoxin clearance status independently of the point of purchase.

Product details

BrandRossiaz Lab
Active ingredientmethenolone acetate
Also known asPrimobolan Tablets, Methenolon Acetate, Primobolan, Rossiaz Lab Primobolan Tablets
Strength25 mg
FormTabletten
Pack size100 pieces
Item numberORA-META-ROS-007

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Primobolan Tablets 25mg/tab 50 Tablets by GenesisLab Tested

Primobolan Tablets 25mg/tab 50 Tabletten by Genesis

€80.00
Primobolan 25mg/tab 50 Tablets by Hilma BiocareHPLC Verified

Primobolan 25mg/tab 50 Tabletten by Hilma Biocare

€76.00
Primoxyl 25mg/tab 50 Tablets by Kalpa PharmaceuticalsPharma Grade

Primoxyl 25mg/tab 50 Tabletten by Kalpa Pharmaceuticals

€76.00
Primobolan Tabs 25mg/tab 50 Tablets by Magnus PharmaceuticalsBatch Tested

Primobolan Tabs 25mg/tab 50 Tabletten by Magnus Pharmaceuticals

€95.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00